Quyen Nguyen Thi, Dr
Research Institute of Stem cell and Gene Technology
Assistant Professor
Email:
quyen.nt2@vinuni.edu.vn
Biography
Dr. Nguyen Thi Quyen received her M.Sc. degree in Biomedical Science from Dong-A University, Busan, Korea, in 2013 and her Ph.D. degree in Biotechnology from the University of Science and Technology, Daejeon, South Korea, in 2020. Her research during this period primarily focused on vaccine development for infectious diseases and monoclonal antibody research. Following her doctoral studies, she dedicated a year to working as a postdoctoral researcher at Chungbuk National University College of Medicine, South Korea, where she primarily assessed the pathogenesis of SARS-CoV-2 and Influenza A virus.
Dr. Quyen received a full scholarship for her Ph.D. program (2014–2020), a scholarship from the International Exchange Program in the USA in 2018, three awards for best poster and oral presentations at international conferences in 2019, an essay award at a STEM forum in 2019, and a dissertation presentation award in 2020.
Since May 2021, she has been a postdoctoral researcher at the Vinmec Research Institute of Stem Cell and Gene Technology. Currently, she is working as a principal investigator or team member on projects aimed at investigating, developing mesenchymal stem cell therapy and extracellular vesicle therapy, and investigating the safety and efficacy of these products for treating human diseases.
Stem cell therapy
Extracellular vesicle therapy
Immunotherapy
Immunology
- Quyen Thi Nguyen#, Nhung Thi Hong Dinh#, Ngo Thu Hang, Can Van Mao, Xuan-Hai Do, Duc Son Le, Hong-Nhung Dao, Ngan Giang T., Nicholas Forsyth, Van T. Hoang, Liem Nguyen Thanh. Safety evaluation of extracellular vesicles derived from hypoxia primed mesenchymal stem cells of umbilical cord and adipose tissue. Scientific Report 2025; (VINUNI) (Q1, IF 3.9)
- Nhung Thi-Hong Dinh#, Quyen Thi Nguyen#, Ngo Thu Hang#, Hong-Nhung Dao, Le Duc Son, Giang Trang Ngan, Can Van Mao, Xuan-Hai Do, Van T. Hoang, Liem Nguyen Thanh. Assessment of the Safety of Hypoxia-Primed Mesenchymal Stem Cells Derived from Umbilical Cord and Adipose Tissues in Animals. Scientific Report 2025; (VINUNI) (Q1, IF 3.9) (co-first author)
- Nguyen Thi Quyen, Nicholas Forsyth. Bone Marrow-Derived Mononuclear Cells and Umbilical Cord Blood-Derived Mononuclear Cells. Cell therapy: Stem cells and Regeneratve Medicine Book chapter, Springer Nature 2025 (VINUNI)
- Nguyen Thanh Liem, Quyen Thi Nguyen. Cell therapy for stroke. Cell therapy: Stem cells and Regeneratve Medicine. Book chapter, Springer Nature 2025 (VINUNI)
- Van T. Hoang*, Quyen Thi Nguyen*, Nhung Thi Hong Dinh, Trang Thi Kieu Phan, Quang-Duong Le, Le Phuong Hoang Anh, Lan Thi Mai Dao, Van Dat Bui, Hong-Nhung Dao, Trang H. Pham, Anh Thi Lan Ngo, Duc Son Le, Liem Nguyen Thanh. Tissue Engineering and Regenerative Medicine: Perspectives and Challenges. Medcomm 2025 (VINUNI) (IF 10) (co-first author)
- Lan T M Dao, Thu Thuy Vu, Quyen Thi Nguyen, Van T Hoang, Thanh Liem Nguyen. Current cell therapies for systemic lupus erythematosus. Stem Cells Transl Med 2024 (IF: 8) (VINMEC)
- Liem Nguyen Thanh, Huong Thu Le, Quyen Thi Nguyen, Dam Thi Minh Phuong, Viet-Anh Bui. Outcomes of cell infusion for the treatment of neurological sequelae induced by spinal anesthesia-associated subdural hematoma: A case report . HELIYON 2024 (IF: 4) (VINMEC)
- Quyen T. Nguyen, Liem Nguyen Thanh, Van T Hoang, Trang T. K. Phan, Michael Heke, Duc M Hoang. Bone Marrow-Derived Mononuclear Cells in the Treatment of Neurological Diseases: Knowns and Unknowns. Cellular and Molecular Neurobiology 2023 (IF: 4) (VINMEC)
- Duc M. Hoang*, Quyen T. Nguyen*, Trang T. K. Phan, Anh T. L. Ngo, Phuong T. Pham, Trung Q. Bach, Phuong T. T. Le, Bui T T Hoa, Liem Nguyen Thanh. Advanced cell-based products generated via automated and manual manufacturing platforms under the quality by design principle: Are they equivalent or different? Heliyon 2023; 9(3):e15946 (Co-first author), (IF:4) (VINMEC)
- Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, Anh T. L. Ngo, Quyen T. Nguyen, Trang T. K. Phan, Giang H. Nguyen, Phuong T. T. Le, Van T. Hoang, Nicholas R. Forsyth, Michael Heke and Liem Thanh Nguyen. Stem cell-based therapy for human diseases. Signal Transduction and Targeted Therapy 2022; 7 (1) (IF:38) (VINMEC)
2014-2020: Ph.D. degree in Biosystems and Bioengineering, Department of Biotechnology, University of
Science and Technology, Daejeon, Republic of Korea
Infectious Disease Research Center, Korea Research Institute of Bioscience and.
Biotechnology, Daejeon, Republic of Korea
2011-2013: M.S degree in Medical Bioscience
Department of Medical Bioscience
Dong-a University, Busan, Republic of Korea
2006-2010: B.S degree in Biotechnology
Department of Biotechnology and Food Technology
Thai Nguyen University of Agricultural and Forestry
Thai Nguyen University, Thai Nguyen, Vietnam
- Dissertation presentation award in KRIBB School, UST, Spring semester 2020, “Study of adjuvant effects on pandemic influenza H1N1 vaccine.” August 2020. Korea Research Institute of Bioscience and Biotechnology.
- Poster presentation award at 11th KRIBB Poster Festival (2019 KRIBB Annual Conference, Daejeon Convention Center, December 04, 2019), “Poly-γ-Glutamic Acid Complexed with Alum Induces Cross Protective Immunity of Pandemic H1N1 Vaccine”.
- Assay award in STEM forum hosted by the Association of Korean Woman Scientists and Engineer (KWSE), December 23, 2019, “Be a “Body” and Take Good Care of every “Single Part”.
- Best poster presentation award at the 46th Annual Meeting and International Symposium. The “Society for Microbiology and Biotechnology (ICC Jeju Island, 23-25th June 2019) “Poly-γ-Glutamic Acid Complexed with Alum Induces Cross Protective Immunity of Pandemic H1N1 Vaccine”.
- Best oral presentation award at the 6th annual conference of Vietnamese Young Scientists (SeoulTech, May 26, 2019) “The complex of Poly-γ-glutamic acid and aluminum salts significantly improves efficacy of pandemic influenza H1N1 vaccine by enhancing antigen delivery and antigen-specific immunogenicity”.
